Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Safety and efficacy of intravenous doripenem for the treatment of complicated urinary tract infections and pyelonephritis.

Journal of chemotherapy (Florence, Italy) - 1 Dec 2010

Redman R, Damiao R, Kotey P, Kaniga K, Davies T, Naber K G

Abstract excerpt

Doripenem was evaluated in adults with complicated urinary tract infections and pyelonephritis in two phase 3 studies. DORI-05, a randomized, double-blind study compared doripenem 500 mg every 8 hours with levofloxacin 250 mg every 24 hours. DORI-06 was a single-arm study designed to confirm the doripenem response in DORI-05. 799 received doripenem, 372 levofloxacin. Microbiological eradication rates in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbapenems
Share to Gram-Negative Bacteria

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gram-Positive Bacteria

Share to Injections, Intravenous

Share to Levofloxacin

Share to Ofloxacin

Share to Pyelonephritis

Share to Urinary Tract Infections

Source

Identifiers

PMID: 21303745
DOI: 10.1179/joc.2010.22.6.384

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Safety and efficacy of intravenous doripenem for the treatment of complicated urinary tract infections and pyelonephritis.PMID 21303745Read ↗

Effectiveness and Safety of Cefiderocol in Clinical Practice for Treatment of Patients with Gram-Negative Bacterial Infections: US Interim Results of the PROVE StudySemantic proximity Read ↗

Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including subsets with molecularly characterized resistance mechanisms and genotypes/epidemiological clones, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3).Semantic proximity Read ↗

Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.Semantic proximity Read ↗

Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative BacteriaSemantic proximity Read ↗

Real‑world effectiveness and safety of cefiderocol in critically ill patients with MDR Gram‑negative infections: Results from a retrospective studySemantic proximity Read ↗

Efficacy and safety of newer antibiotics versus generic antibiotics for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: a systematic review and meta-analysis of randomized controlled trialsSemantic proximity Read ↗

Clinical outcomes of flomoxef versus cefmetazole in hospitalized patients with urinary tract infections: Combined retrospective analyses of two real-world databases and<i>in vitro</i>dataSemantic proximity Read ↗

Appropriateness and Abuse of Antipyretics, Anti-Inflammatory Drugs and Antibiotics in Children and AdultsSemantic proximity Read ↗

Antimicrobial Prescription Practices for Outpatients with Cystitis: A Multicenter, Medical Record-Based StudySemantic proximity Read ↗

Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.Semantic proximity Read ↗

PNFLBA-02 A HEAD TO HEAD COMPARATIVE PHASE II TRIAL OF STANDARD URINE CULTURE AND SENSITIVITY VERSUS DNA NEXT GENERATION SEQUENCING TESTING FOR URINARY TRACT INFECTIONSSemantic proximity Read ↗

Comparative Efficacy and Safety of Generic vs Brand-Name Meropenem for Anti-infective Use in Real-worldSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.